200,000+ products from a single source!

sales@angenechem.com

Home > Indoles and Oxindole > 121679-13-8

121679-13-8

121679-13-8 | 1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-

CAS No: 121679-13-8 Catalog No: AG0015K1 MDL No:MFCD00866221

Product Description

Catalog Number:
AG0015K1
Chemical Name:
1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-
CAS Number:
121679-13-8
Molecular Formula:
C17H25N3O2S
Molecular Weight:
335.4643
MDL Number:
MFCD00866221
IUPAC Name:
N-methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide
InChI:
InChI=1S/C17H25N3O2S/c1-18-23(21,22)10-7-13-3-4-17-15(11-13)16(12-19-17)14-5-8-20(2)9-6-14/h3-4,11-12,14,18-19H,5-10H2,1-2H3
InChI Key:
AMKVXSZCKVJAGH-UHFFFAOYSA-N
SMILES:
CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C
EC Number:
601-800-8
UNII:
QX3KXL1ZA2

Properties

Complexity:
483  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
335.167g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
335.466g/mol
Monoisotopic Mass:
335.167g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
73.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2  

Literature

Title Journal
Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. Nature medicine 20121001
Differential effects of calcitonin gene-related peptide receptor blockade by olcegepant on mechanical allodynia induced by ligation of the infraorbital nerve vs the sciatic nerve in the rat. Pain 20120901
Challenges in the simultaneous quantitation of sumatriptan and naproxen in human plasma: application to a bioequivalence study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120801
[Extensive mesenteric ischemia related to naratriptan overuse associated with grapefruit juice absorption]. Annales francaises d'anesthesie et de reanimation 20120501
Italian guidelines for primary headaches: 2012 revised version. The journal of headache and pain 20120501
[Pediatric poisoning with triptans: review of cases in the Lille poison center between 2000 and 2010]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20120301
Spinal trigeminal neurons demonstrate an increase in responses to dural electrical stimulation in the orofacial formalin test. The journal of headache and pain 20120101
Migraine-like headache in a patient with complement 1 inhibitor deficient hereditary angioedema. Journal of Korean medical science 20120101
Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache. Patient preference and adherence 20120101
Headache in pregnancy: a nuisance or a new sense? Obstetrics and gynecology international 20120101
Reduction of current migraine headache pain following neck massage and spinal manipulation. International journal of therapeutic massage & bodywork 20120101
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. The journal of headache and pain 20111201
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Quantitative analysis of eletriptan in human plasma by HPLC-MS/MS and its application to pharmacokinetic study. Analytical and bioanalytical chemistry 20111101
Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms. Pain 20111001
Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register. The journal of headache and pain 20110801
Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization? The journal of headache and pain 20110801
Guidelines on the diagnosis and the current management of headache and related disorders. Annals of Indian Academy of Neurology 20110701
Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment. The journal of headache and pain 20110601
Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people. Cephalalgia : an international journal of headache 20110601
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110501
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. The journal of headache and pain 20110401
Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG). The journal of headache and pain 20110401
Rizatriptan reduces vestibular-induced motion sickness in migraineurs. The journal of headache and pain 20110201
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. The journal of headache and pain 20110201
Acute migraine therapy: new drugs and new approaches. Current treatment options in neurology 20110201
Development and validation of a sensitive and rapid method to determine naratriptan in human plasma by LC-ESI-MS-MS: application to a bioequivalence study. Journal of chromatographic science 20110201
Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design. Headache 20110101
IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells. PloS one 20110101
Migraine attacks the Basal Ganglia. Molecular pain 20110101
The use of triptans for pediatric migraines. Paediatric drugs 20101201
Prevention and treatment of menstrual migraine. Drugs 20101001
The natural diatomite from caldiran-van (Turkey): electroanalytical application to antimigraine compound naratriptan at modified carbon paste electrode. Combinatorial chemistry & high throughput screening 20100901
Triptans for the management of migraine. Drugs 20100820
Voltammetric behavior of naratriptan and its determination in tablets. Talanta 20100715
Safety of triptans for migraine headaches during pregnancy and breastfeeding. Canadian family physician Medecin de famille canadien 20100601
Drug dependence associated with triptans and ergot derivatives: a case/non-case study. European journal of clinical pharmacology 20100401
Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. Headache 20100401
Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial. Journal of clinical neurology (Seoul, Korea) 20100301
Pure naratriptan-induced ischemic colitis: a case report. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100301
Development and Validation of HPTLC Method for the Estimation of Rizatriptan Benzoate in Bulk and Tablets. Indian journal of pharmaceutical sciences 20100101
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance. Current cardiology reviews 20090801
Optimized method for the determination of itopride in human plasma by high-performance liquid chromatography with fluorimetric detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090315
Clinical aspects of perimenstrual headaches. Current pain and headache reports 20090201
Individual triptan selection in migraine attack therapy. Recent patents on CNS drug discovery 20090101
Obsessive-compulsive disorder and related disorders: a comprehensive survey. Annals of general psychiatry 20090101
Triptans and troponin: a case report. Orphanet journal of rare diseases 20090101
The safety of sumatriptan and naratriptan in pregnancy: what have we learned? Headache 20090101
Migraine: an overview. The open neurology journal 20090101
Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life. Patient preference and adherence 20090101
Halide salts of antimigraine agents eletriptan and naratriptan. Acta crystallographica. Section C, Crystal structure communications 20081201
Current migraine management - patient acceptability and future approaches. Neuropsychiatric disease and treatment 20081201
Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatric disease and treatment 20081201
Optimizing prophylactic treatment of migraine: Subtypes and patient matching. Therapeutics and clinical risk management 20081001
Prediction of attack frequency in migraine treatment. Cephalalgia : an international journal of headache 20080801
Maximum effect of triptans in migraine? A comment. Cephalalgia : an international journal of headache 20080701
Indolealkylamines: biotransformations and potential drug-drug interactions. The AAPS journal 20080601
Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology 20080422
Use of 5-HT1 agonists in pregnancy. The Annals of pharmacotherapy 20080401
Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. Headache 20080201
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. The journal of headache and pain 20080201
Triptans in pregnancy. Therapeutic drug monitoring 20080201
Review of frovatriptan in the treatment of migraine. Neuropsychiatric disease and treatment 20080201
Triptan drugs, natural killer cell cytotoxicity, and neutrophils pro-matrix metalloproteinase-9 secretion. Headache 20080101
Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. Molecular pain 20080101
Temporary confusion depending on the usage of naratriptan. The journal of headache and pain 20071201
Almotriptan in the treatment of migraine. Neuropsychiatric disease and treatment 20071201
[The Vigimig study of naratriptan use in general practice]. Presse medicale (Paris, France : 1983) 20071101
Serotonin, 5-HT 1B/1D receptor, agonists are effective in acute benign lymphocytic meningitis--a case report. Cephalalgia : an international journal of headache 20071001
Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment. The journal of headache and pain 20071001
Menstrually related migraine: breaking the cycle in your clinical practice. The Journal of reproductive medicine 20071001
Economic analysis of triptan therapy for acute migraine: a Medicaid perspective. Pharmacotherapy 20070801
Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. International journal of clinical practice 20070701
Characterization of the human basilar artery contractile response to 5-HT and triptans. Fundamental & clinical pharmacology 20070601
Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. Headache 20070601
Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine. Headache 20070601
Acute migraine: Current treatment and emerging therapies. Therapeutics and clinical risk management 20070601
[Naratriptan. A new medical option for the pharmacist]. Medizinische Monatsschrift fur Pharmazeuten 20070501
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. CNS drugs 20070101
Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. Headache 20070101
Over-the-counter triptans for migraine : what are the implications? CNS drugs 20070101
[Prophylactic measures and acute treatment of migraine]. Schmerz (Berlin, Germany) 20061101
A review of evidence-based medicine and meta-analytic reviews in migraine. Cephalalgia : an international journal of headache 20061101
A model-based approach to treatment comparison in acute migraine. British journal of clinical pharmacology 20061101
Tailoring management strategies for the patient with menstrual migraine: focus on prevention and treatment. Headache 20061001
Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target? Neurobiology of disease 20060901
Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine. Therapeutics and clinical risk management 20060901
Rizatriptan in the treatment of migraine. Neuropsychiatric disease and treatment 20060901
Prophylaxis of migraine. Neuropsychiatric disease and treatment 20060901
Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials. Cephalalgia : an international journal of headache 20060201
[Medical treatment of migraine attacks in the child]. Revue de l'infirmiere 20060101
Antimigraine drug, zolmitriptan, inhibits high-voltage activated calcium currents in a population of acutely dissociated rat trigeminal sensory neurons. Molecular pain 20060101
Eletriptan: a review of its use in the acute treatment of migraine. Drugs 20060101
[Clinical use of triptans in the management of migraine]. CNS drugs 20060101
Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy. American journal of therapeutics 20060101
Spotlight on eletriptan in migraine. CNS drugs 20060101
A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. PloS one 20060101
Uncertainty analysis in pharmacokinetics and pharmacodynamics: application to naratriptan. Pharmaceutical research 20051001
Efficacy of oral naratriptan in the treatment of menstrually related migraine. European journal of neurology 20051001
[The role of triptans and analgesics for primary headache treatment]. Nihon rinsho. Japanese journal of clinical medicine 20051001
The use of multiattribute decision models in evaluating triptan treatment options in migraine. Journal of neurology 20050901
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat. Journal of managed care pharmacy : JMCP 20050601
The combination of naratriptan and prochlorperazine in migraine treatment. Headache 20050601
Prediction of genotoxicity of chemical compounds by statistical learning methods. Chemical research in toxicology 20050601
Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology. Biological psychiatry 20050515
Triptans induce vasoconstriction of human arteries and veins from the thoracic wall. Journal of cardiovascular pharmacology 20050501
Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050501
Naratriptan in the short-term prophylaxis of pure menstrual migraine. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050501
[Economic evaluation of acute migraine attack treatment with triptans in Spain]. Neurologia (Barcelona, Spain) 20050401
Ischemic colitis associated with naratriptan and oral contraceptive use. Headache 20050401
Eletriptan review. Expert opinion on pharmacotherapy 20050401
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties. Naunyn-Schmiedeberg's archives of pharmacology 20050301
Correlation between lipophilicity and triptan outcomes. Headache 20050101
An economic evaluation of rizatriptan in the treatment of migraine. PharmacoEconomics 20050101
[Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal]. Acta medica portuguesa 20050101
The use of triptans in the management of menstrual migraine. CNS drugs 20050101
Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study. Headache 20050101
Ischemic colitis associated with naratriptan and oral contraceptive use: a response. Headache 20050101
Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine. PharmacoEconomics 20050101
Preclinical neuropharmacology of naratriptan. CNS drug reviews 20050101
Colonic ischemia associated with naratriptan use. Journal of clinical gastroenterology 20041001
Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Annals of neurology 20040901
[Meta-analysis of triptan treatment in migraine]. No to shinkei = Brain and nerve 20040901
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery. Naunyn-Schmiedeberg's archives of pharmacology 20040701
The sumatriptan/naratriptan aggregated patient (SNAP) database: aggregation, validation and application. Cephalalgia : an international journal of headache 20040701
Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms. Cephalalgia : an international journal of headache 20040601
Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. Cephalalgia : an international journal of headache 20040601
Migraine headache. Clinical evidence 20040601
Cost considerations of acute migraine treatment. Headache 20040301
The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. Brain research 20040213
[Recent progress in therapy for migraine headache]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040210
Naratriptan has a selective inhibitory effect on trigeminovascular neurones at central 5-HT1A and 5-HT(1B/1D) receptors in the cat: implications for migraine therapy. Cephalalgia : an international journal of headache 20040201
Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. Pharmacoepidemiology and drug safety 20040201
Triptans and gastric accommodation: pharmacological and therapeutic aspects. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040101
Patterns of use of triptans and reasons for switching them in a tertiary care migraine population. Headache 20040101
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC neurology 20040101
Efficacy of quality criteria to identify potentially harmful information: a cross-sectional survey of complementary and alternative medicine web sites. Journal of medical Internet research 20040101
[Treatment of migraine]. Medicinski arhiv 20040101
Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. Cephalalgia : an international journal of headache 20031201
Out-patient detoxification in chronic migraine: comparison of strategies. Cephalalgia : an international journal of headache 20031201
Migraine headache. Clinical evidence 20031201
Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. Cephalalgia : an international journal of headache 20031101
Investigation of the effects of naratriptan, rizatriptan, and sumatriptan on jugular venous oxygen saturation in anesthetized pigs: implications for their mechanism of acute antimigraine action. The Journal of pharmacology and experimental therapeutics 20031001
Managing intractable migraine with naratriptan. Headache 20031001
Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study. Headache 20030901
Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein. Drug metabolism and disposition: the biological fate of chemicals 20030701
S+ -flurbiprofen but not 5-HT1 agonists suppress basal and stimulated CGRP and PGE2 release from isolated rat dura mater. Pain 20030601
[Improved pharmacokinetics. Fast tryptan with sustained response]. MMW Fortschritte der Medizin 20030526
[Highly selective beginning. Associated symptoms and side effects in retrospect]. MMW Fortschritte der Medizin 20030526
Demographic and migraine characteristics of adolescents with migraine: Glaxo Wellcome clinical trials' database. Headache 20030501
Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases. Headache 20030501
[A descriptive analysis of naratriptan use among migraineurs in ambulatory medicine]. Revue neurologique 20030501
Safety profile of the triptans. Expert opinion on drug safety 20030301
Migraine: pathophysiology, pharmacology, treatment and future trends. Current vascular pharmacology 20030301
[Early, but not unnecessarily frequent administration. What is proper timing for triptan drugs?]. MMW Fortschritte der Medizin 20030116
Pharmacological approaches to migraine. Journal of neural transmission. Supplementum 20030101
Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients. Headache 20030101
Migraine: diagnosis and management. Internal medicine journal 20030101
Newer formulations of the triptans: advances in migraine management. Drugs 20030101
Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours. Journal of managed care pharmacy : JMCP 20030101
Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Neuroscience 20030101
Naratriptan in the preventive treatment of cluster headache. Cephalalgia : an international journal of headache 20021201
[Ischemic colitis associated with naratriptan administration]. Gastroenterologie clinique et biologique 20021101
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology 20021101
Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia : an international journal of headache 20021001
Triptans reduce the inflammatory response in bacterial meningitis. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20020801
Selegiline: a second look. Six years later: too risky in Parkinson's disease. Prescrire international 20020801
Mechanisms of action of the 5-HT1B/1D receptor agonists. Archives of neurology 20020701
Pharmacological treatments for acute migraine: quantitative systematic review. Pain 20020601
Gateways to Clinical Trials. June 2002. Methods and findings in experimental and clinical pharmacology 20020601
Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid artery. British journal of pharmacology 20020501
Gateways to Clinical Trials. Methods and findings in experimental and clinical pharmacology 20020401
The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons. Neuropharmacology 20020301
Migraine: diagnosis, management, and new treatment options. The American journal of managed care 20020201
Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain. Headache 20020201
Health needs, drug registration and control in less developed countries--the Peruvian case. Pharmacoepidemiology and drug safety 20020101
Naratriptan in the prophylaxis of cluster headache. Headache 20020101
Rizatriptan: an update of its use in the management of migraine. Drugs 20020101
Validation of the Patient Perception of Migraine Questionnaire. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20020101
Spotlight on rizatriptan in migraine. CNS drugs 20020101
Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials. European neurology 20020101
An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proceedings of the Western Pharmacology Society 20020101
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (London, England) 20011117
Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology 20011113
[Cost effectiveness of treatment with triptanes in Spain]. Revista de neurologia 20011101
Comparison of rizatriptan and other triptans on stringent measures of efficacy. Neurology 20011023
Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons. International journal of clinical practice 20011001
Advances in pharmacological treatment of migraine. Expert opinion on investigational drugs 20011001
Have the triptans fulfilled their promise? Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20010901
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis. Headache 20010901
Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan. Pharmaceutical research 20010801
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). Archives of neurology 20010701
Intranasal absorption of sumatriptan and naratriptan: no evidence of local transfer from the nasal cavities to the brain arterial blood in male rats. Biopharmaceutics & drug disposition 20010701
Headache and female hormones: what you need to know. Current opinion in neurology 20010601
Current options for the prevention and treatment of migraine. Clinical therapeutics 20010601
Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study. Clinical therapeutics 20010601
Treatment of migraine in Canada with naratriptan: a cost-effectiveness analysis. Headache 20010501
[Current topics: expectation for new triptans]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20010410
Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 20010301
Gastric motor effects of triptans: open questions and future perspectives. Pharmacological research 20010301
Donitriptan (Pierre Fabre). Current opinion in investigational drugs (London, England : 2000) 20010301
Acute treatment of migraine and the role of triptans. Current neurology and neuroscience reports 20010301
Modulation of neuronal activity in the nucleus raphé magnus by the 5-HT(1)-receptor agonist naratriptan in rat. Pain 20010215
Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine. Journal of clinical pharmacology 20010201
A systematic review of the use of triptans in acute migraine. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20010201
Naratriptan prophylactic treatment in cluster headache. Cephalalgia : an international journal of headache 20010201
New abortive agents for the treatment of migraine. Advances in internal medicine 20010101
Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review. Clinical pharmacokinetics 20010101
Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience. Cephalalgia : an international journal of headache 20010101
Building on the sumatriptan experience: the development of naratriptan. Cephalalgia : an international journal of headache 20010101
Looking forward: the expanding utility of sumatriptan and naratriptan. Cephalalgia : an international journal of headache 20010101
Sumatriptan: pharmacological basis and clinical results. Current medical research and opinion 20010101
Naratriptan. Current medical research and opinion 20010101
Comparative aspects of triptans in treating migraine. Clinical cornerstone 20010101
[Quality of life of migraine patients after treatment with 2.5 mg oral naratriptan]. Presse medicale (Paris, France : 1983) 20001209
Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness? Cephalalgia : an international journal of headache 20001001
Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. Clinical therapeutics 20000801
Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence. Headache 20000201
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. Acta neurologica Belgica 19990601
Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. European journal of pharmacology 19990305
N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist. Journal of medicinal chemistry 19990211
Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 19980707
Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist. Naunyn-Schmiedeberg's archives of pharmacology 19970901
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy. Naunyn-Schmiedeberg's archives of pharmacology 19970601
Naratriptan: biological profile in animal models relevant to migraine. Cephalalgia : an international journal of headache 19970501
5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. British journal of pharmacology 19950301

© 2019 Angene International Limited. All rights Reserved.